Mepitiostane
Mepitiostane is an ethylestrenol ether and a synthetic, orally active androgen and anabolic steroid (AAS) that is used in the treatment of breast cancer. It is marketed under the brand name Thioderon. Mepitiostane is a prodrug of ethylestrenol, meaning it is metabolically converted into ethylestrenol within the body. This conversion is necessary for its activity, as ethylestrenol is the active form of the drug.
Medical Uses[edit | edit source]
Mepitiostane is primarily used in the treatment of breast cancer in women. Its effectiveness in this application is attributed to its ability to reduce estrogen levels in the body, which can help to slow the growth of estrogen-sensitive cancer cells.
Pharmacology[edit | edit source]
Mechanism of Action[edit | edit source]
As an androgen and anabolic steroid, mepitiostane's mechanism of action involves its conversion to ethylestrenol, which then exerts anabolic and androgenic effects. These effects are mediated through the activation of the androgen receptor (AR), leading to various physiological and pharmacological outcomes. In the context of breast cancer, the reduction in estrogen levels is a key therapeutic effect.
Pharmacokinetics[edit | edit source]
Mepitiostane is administered orally. Upon ingestion, it is converted into ethylestrenol, its active metabolite. The pharmacokinetics of mepitiostane, including its absorption, distribution, metabolism, and excretion, are closely tied to those of ethylestrenol.
Adverse Effects[edit | edit source]
Like other androgens and anabolic steroids, mepitiostane can cause a range of adverse effects. These may include virilization in women, hepatotoxicity, alterations in lipid profiles, and changes in libido. The severity and occurrence of these side effects can vary based on the dosage and duration of treatment.
Contraindications[edit | edit source]
Mepitiostane is contraindicated in patients with known hypersensitivity to the drug or its components. It is also contraindicated in individuals with prostate cancer, as androgens can accelerate the growth of prostate cancer cells. Pregnant and breastfeeding women should avoid using mepitiostane due to potential risks to the fetus or infant.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD